Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study

    NEXT STORY
    Fortress Biotech Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
    PREV STORY
    Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer

    author_avatar
    NASDAQ Market News

    Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting

    CALGARY, Alberta and SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...

    author_avatar
    NASDAQ Market News

    North America Hand Sanitizer Market to 2027 – Regional Analysis and Forecasts by Type ; Product form ; Application ; Distribution Channel     

    author_avatar
    NASDAQ Market News